Patient-to-patient transmission of natalizumab-associated PML?

Mult Scler. 2017 Oct;23(11):1564-1565. doi: 10.1177/1352458517701316. Epub 2017 Mar 20.

Authors

Reinhard Hohlfeld¹, Joachim Havla¹, Tania Kümpfel¹

Affiliation

¹ Institute of Clinical Neuroimmunology, Biomedical Center and University Hospital, Ludwig Maximilians University, Munich, Germany; Munich Cluster for Systems Neurology (SyNergy), Ludwig Maximilians University, Munich, Germany.

PMID: 28318370
DOI: 10.1177/1352458517701316

No abstract available

Publication types

Letter
Comment

MeSH terms

Humans
Immunologic Factors
JC Virus / immunology
Leukoencephalopathy, Progressive Multifocal*
Natalizumab*

Substances

Immunologic Factors
Natalizumab